These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 11011957)

  • 1. Androgen receptor--an update of mechanisms of action in prostate cancer.
    Culig Z; Hobisch A; Bartsch G; Klocker H
    Urol Res; 2000 Aug; 28(4):211-9. PubMed ID: 11011957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Androgen receptors in prostate cancer.
    Culig Z; Klocker H; Bartsch G; Steiner H; Hobisch A
    J Urol; 2003 Oct; 170(4 Pt 1):1363-9. PubMed ID: 14501770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and function of androgen receptor coactivators in prostate cancer.
    Culig Z; Comuzzi B; Steiner H; Bartsch G; Hobisch A
    J Steroid Biochem Mol Biol; 2004 Nov; 92(4):265-71. PubMed ID: 15663989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgen receptor mutations in carcinoma of the prostate: significance for endocrine therapy.
    Culig Z; Klocker H; Bartsch G; Hobisch A
    Am J Pharmacogenomics; 2001; 1(4):241-9. PubMed ID: 12083956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androgen receptor signaling in prostate cancer.
    Culig Z; Santer FR
    Cancer Metastasis Rev; 2014 Sep; 33(2-3):413-27. PubMed ID: 24384911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androgen-receptor gene structure and function in prostate cancer.
    Hakimi JM; Rondinelli RH; Schoenberg MP; Barrack ER
    World J Urol; 1996; 14(5):329-37. PubMed ID: 8912473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Androgen receptors in prostate cancer.
    Culig Z; Klocker H; Bartsch G; Hobisch A
    Endocr Relat Cancer; 2002 Sep; 9(3):155-70. PubMed ID: 12237244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Androgen receptor: a key molecule in the progression of prostate cancer to hormone independence.
    Taplin ME; Balk SP
    J Cell Biochem; 2004 Feb; 91(3):483-90. PubMed ID: 14755679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen receptor in prostate cancer.
    Heinlein CA; Chang C
    Endocr Rev; 2004 Apr; 25(2):276-308. PubMed ID: 15082523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gum mastic inhibits the expression and function of the androgen receptor in prostate cancer cells.
    He ML; Yuan HQ; Jiang AL; Gong AY; Chen WW; Zhang PJ; Young CY; Zhang JY
    Cancer; 2006 Jun; 106(12):2547-55. PubMed ID: 16691616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgen receptor corepressors and prostate cancer.
    Burd CJ; Morey LM; Knudsen KE
    Endocr Relat Cancer; 2006 Dec; 13(4):979-94. PubMed ID: 17158750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The androgen receptor (AR) in syndromes of androgen insensitivity and in prostate cancer.
    Avila DM; Zoppi S; McPhaul MJ
    J Steroid Biochem Mol Biol; 2001; 76(1-5):135-42. PubMed ID: 11384871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minireview: Alternative activation pathways for the androgen receptor in prostate cancer.
    Lamont KR; Tindall DJ
    Mol Endocrinol; 2011 Jun; 25(6):897-907. PubMed ID: 21436259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of the androgen receptor in the development and progression of prostate cancer.
    Jenster G
    Semin Oncol; 1999 Aug; 26(4):407-21. PubMed ID: 10482183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgen Receptor Coactivators in Regulation of Growth and Differentiation in Prostate Cancer.
    Culig Z
    J Cell Physiol; 2016 Feb; 231(2):270-4. PubMed ID: 26201947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of two mutant androgen receptors from human prostatic carcinoma by adrenal androgens and metabolic derivatives of testosterone.
    Culig Z; Stober J; Gast A; Peterziel H; Hobisch A; Radmayr C; Hittmair A; Bartsch G; Cato AC; Klocker H
    Cancer Detect Prev; 1996; 20(1):68-75. PubMed ID: 8907206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered corepressor SMRT expression and recruitment to target genes as a mechanism that change the response to androgens in prostate cancer progression.
    Godoy AS; Sotomayor PC; Villagran M; Yacoub R; Montecinos VP; McNerney EM; Moser M; Foster BA; Onate SA
    Biochem Biophys Res Commun; 2012 Jul; 423(3):564-70. PubMed ID: 22695118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgen deprivation increases p300 expression in prostate cancer cells.
    Heemers HV; Sebo TJ; Debes JD; Regan KM; Raclaw KA; Murphy LM; Hobisch A; Culig Z; Tindall DJ
    Cancer Res; 2007 Apr; 67(7):3422-30. PubMed ID: 17409453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anti-apoptotic effect of the androgen receptor in human prostate cancer].
    Shen FY; Li BY
    Zhonghua Nan Ke Xue; 2007 Dec; 13(12):1121-4. PubMed ID: 18284065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of novel androgen receptor target genes in prostate cancer.
    Jariwala U; Prescott J; Jia L; Barski A; Pregizer S; Cogan JP; Arasheben A; Tilley WD; Scher HI; Gerald WL; Buchanan G; Coetzee GA; Frenkel B
    Mol Cancer; 2007 Jun; 6():39. PubMed ID: 17553165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.